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Background
The national second-line Anti retroviral Therapy (ART)
programme was started in Kolkata in December 2008. It
included a combination of Tenofovir, Lamivudine and
Ritonavir-boosted Lopinavir ± Zidovudine. Dyslipidae-
mia and increased fasting blood sugar (FBS) often com-
plicate protease inhibitor-containing ART. Thus a
prospective study was designed to observe the above
changes.
Methods
The data of 48 patients, on protease inhibitor for one
year were analyzed. Body Mass Index (BMI), grip
strength (GS), Triceps skin fold (TSF), 24 hour dietary
recall, serum triglyceride (TG), total cholesterol (TC),
HDL, LDL, VLDL and FBS were estimated for all
patients at baseline, 6 months and after one year.
Results
There was a significant increase in TG, TC and VLDL
levels at 1 year as compared to baseline (p=0.013, 0.00
and 0.00 respectively) whereas LDL significantly
increased at 6 months only (p=0.029). HDL decreased
significantly at 6 months (p=0.019). TSF significantly
decreased both at 6 and 12 months (p=0.00 and 0.00
respectively). The BMI and GS showed a significant
increase at both 6 months (p=0.001, 0.000 respectively)
and 1 year (p=0.005 and 0.00 respectively). Four patients
with normal baseline FBG and one with impaired fasting
glucose progressed to overt diabetes (FBG > 124 mg/dl)
at 12 months. No significant change was noted in
energy and protein intake of patients.
Conclusion
There is an increased incidence of dyslipidaemia and
unmasking of diabetes related to protease inhibitor in
this cohort. There has been an improvement in nutri-
tional status as shown by BMI and GS.
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